Explorer les evidences

31,8 %Among 66 HBsAg-positive patients, 31.8% had HBeAg-positive hepatitis.

Côte d'Ivoirehépatite B · VIH/sidaobservé 2006publié 2012World journal of hepatologyeurope_pmcdocument de 13 observations

4,6 %Plasmodium ovale was detected in 4.6% of febrile people in Côte d'Ivoire.

Côte d'Ivoirepaludismepublié 2021Travel medicine and infectious diseasePubMeddocument de 25 observations

1,29 per_100_person_monthsDuring the pre-intervention period, the malaria incidence rate was 1.29 cases per 100 person-months in the LLIN plus Bti group.

Côte d'IvoirepaludismeHAL · Unilimdocument de 54 observations

185 cells/μlThe median baseline CD4 cell count among HIV-2-infected individuals initiating antiretroviral therapy was 185 cells/μl.

Côte d'IvoireVIH/sidapublié 2016AIDS (London, England)europe_pmcdocument de 6 observations

Early antiretroviral therapy decreased the risk of AIDS, tuberculosis, invasive bacterial diseases and Kaposi's sarcoma considered separately.

Côte d'Ivoireinvasive bacterial diseases · Kaposi's sarcoma · tuberculose · VIH/sidapublié 2016AIDS research and therapyeurope_pmcdocument de 5 observations

8 427 participantsThree randomized controlled trials — HPTN 052, Temprano ANRS 12136 and START — recruited 8427 HIV-infected adults in 37 countries.

Côte d'IvoireVIH/sidapublié 2016AIDS research and therapyeurope_pmcdocument de 5 observations

19 casesNineteen cases of TB-IRIS occurred in the raltegravir arm and 29 cases in the efavirenz arm.

Côte d'IvoireTB-IRISpublié 2024Open forum infectious diseaseseurope_pmcdocument de 9 observations

24 per_100_person_yearsThe incidence rate of serious HIV-related events was 24.0 per 100 person-years among HIV-HBV co-infected patients with baseline HBV-replication > 10,000 copies/mL.

Côte d'Ivoirehépatite B · VIH/sidapublié 2017The American journal of tropical medicine and hygieneeurope_pmcdocument de 7 observationsDOI 10.4269/ajtmh.16-1016

35 %Among the 975 first participants, 35% had a positive QFT-GIT test.

Côte d'Ivoiretuberculosepublié 2014PloS oneeurope_pmcdocument de 8 observations

0,8 sensitivityBaseline qHBsAg ≤ 1000 IU/mL had sensitivity of 0.80 and specificity of 0.80 for predicting HBsAg seroclearance at month 36.

Côte d'Ivoirehépatite Bobservé month 36publié 2016Journal of gastroenterology and hepatologyeurope_pmcdocument de 11 observationsDOI 10.1111/jgh.13156

15 %Among hospitalized HIV-positive adults in West Africa, pneumonia was diagnosed in 15% of patients.

Côte d'Ivoirepneumonie · VIH/sidaobservé 2010publié 2014Journal of the International AIDS Societyeurope_pmcdocument de 22 observationsDOI 10.7448/ias.17.1.18797

2,04 aORUrine LAM positivity was significantly associated with severe morbidity (aOR = 2.04, 95% CI, 1.06–3.92, p = .0323).

Côte d'Ivoiretuberculosepublié 2025BMC infectious diseaseseurope_pmcdocument de 9 observations

7,2 %At baseline, 7.2% of participants were obese.

Côte d'IvoireVIH/sidapublié 2016AIDS research and therapyeurope_pmcdocument de 9 observations

0,87 per_100_person_monthsDuring the post-intervention period, the malaria incidence rate was 0.87 cases per 100 person-months in the LLIN-alone control group.

Côte d'IvoirepaludismeHAL · Unilimdocument de 54 observations

100 %Among eight patients with severe hyperlactatemia, 100% experienced greater than 9% body weight loss before diagnosis.

Côte d'Ivoiresevere hyperlactatemiapublié 2010AIDS research and human retroviruseseurope_pmcdocument de 12 observations

2,1 hazard_ratioIn univariate analysis, the hazard ratio of death was 2.10 (95% CI, 1.38–3.21) for patients with HIV-1 RNA ≥5 log10 copies/ml vs. others in the Temprano trial.

Côte d'IvoireVIH/sidapublié 2020EBioMedicineeurope_pmcdocument de 7 observations

19,2 %In a cohort of HIV-infected patients of sub-Saharan African origin, the cumulative incidence of insulin resistance was 19.2% after 3 years of combined antiretroviral therapy.

Côte d'Ivoireinsulin resistance · VIH/sidapublié 2015AIDS research and human retroviruseseurope_pmcdocument de 7 observations

1,66 mean_complexityThe overall complexity of infection was 1.66 (SD = 0.79) in Côte d'Ivoire.

Côte d'Ivoirepaludismepublié 2016Journal of parasitology researcheurope_pmcdocument de 8 observationsDOI 10.1155/2016/3074803

100 %Among eight patients with severe hyperlactatemia, 100% had serum lactate levels greater than 4 mmol/liter, ranging from 4.2 to 12.1 mmol/liter.

Côte d'Ivoiresevere hyperlactatemiapublié 2010AIDS research and human retroviruseseurope_pmcdocument de 12 observations

25,9 %Among 879 participants in the Temprano randomized control trial, 228 (25.9%) were HBV non-immune/vaccinated (HBcAb-negative).

Côte d'Ivoirehépatite Bobservé 2008 and 2015publié 2021Journal of viral hepatitiseurope_pmcdocument de 5 observations

12,9 %A total of 4 (12.9%) HIV-2 patients were lost to follow-up.

Côte d'IvoireVIH/sidapublié 2020PloS oneeurope_pmcdocument de 13 observationsDOI 10.1371/journal.pone.0236642

1 021 patientsAmong the 1,754 patients, 1,021 were HIV-2 infected.

Côte d'IvoireVIH/sidapublié 2013PloS oneeurope_pmcdocument de 14 observations

41,9 %After 24 months of follow-up, 13 out of 31 patients (41.9%) were lost to follow-up.

Côte d'Ivoireméningite cryptococciquepublié 2025IJID regionseurope_pmcdocument de 11 observations

29 %Among hospitalized HIV-positive adults in West Africa, tuberculosis was the most frequent disease diagnosed, occurring in 29% of patients.

Côte d'Ivoiretuberculose · VIH/sidaobservé 2010publié 2014Journal of the International AIDS Societyeurope_pmcdocument de 22 observationsDOI 10.7448/ias.17.1.18797

50 yearsThe median age of the HIV-2 patients was 50 years.

Côte d'IvoireVIH/sidapublié 2020PloS oneeurope_pmcdocument de 13 observationsDOI 10.1371/journal.pone.0236642